Table 1.
Baseline characteristics of subjects.
| Healthy (n = 106) | LC (n = 106) | HCC (n = 167) | Siga | |
|---|---|---|---|---|
| Gender (M, %) | 51.9 | 52.8 | 58.7 | ∗ |
| Age (M ± S.E.) | 51.56 ± 9.57 | 52.08 ± 9.44 | 57.14 ± 10.1 | ∗ |
| Stage (%) | Compensated: 64.15 | BCLC 0: 5.39 | ||
| Decompensated: 35.85 | BCLC A: 16.17 | |||
| BCLC B: 28.14 | ||||
| BCLC C: 38.32 | ||||
| BCLC D: 11.98 | ||||
| HBsAg (positive, %) | 90.6 | 89.8 | n.s. | |
| AFPb (ng/ml) | 3.75 (2.09-5.88) | 7.81 (3.69-19.74) | 9.27 (5.42-31.13) | ∗∗ |
| CA199b (ng/ml) | 16.36 (9.38-23.54) | 18.71 (5.79-41.57) | 19.85 (8.36-39.63) c | ∗ |
aComparison between 3 groups. bData were presented as median with quartile (Q1-Q3). cNot significant vs. LC. LC: liver cirrhosis; HCC: hepatocellular carcinoma; n.s.: not significant. ∗p < 0.05, ∗∗p < 0.01, and∗∗∗∗p < 0.0001.